REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDirecta Plus Regulatory News (DCTA)

Share Price Information for Directa Plus (DCTA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 19.20
Bid: 18.40
Ask: 20.00
Change: 0.50 (2.67%)
Spread: 1.60 (8.696%)
Open: 18.70
High: 19.20
Low: 18.00
Prev. Close: 18.70
DCTA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Agreement with REDA Energy for Grafysorber

19 Jul 2022 07:00

RNS Number : 8773S
Directa Plus PLC
19 July 2022
 

19 July 2022

 

Directa Plus plc

("Directa Plus" or the "Company")

 

Commercial Agreement with REDA Energy Ltd to Distribute Grafysorber Products

 

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelet based products for use in consumer and industrial markets, announces that it has signed a Commercial Agreement ("the Agreement") with REDA Energy Ltd ("REDA") to distribute Grafysorber® oil response products in certain agreed territories. REDA, a division of the REDA Group, is a leading Tier 1 chemical manufacturer and supplier of products and services to global oil and gas sector.

 

The Commercial Agreement follows successful testing of the products by REDA customers in the North Sea. These customers particularly appreciated the lightness and simplicity in handling, the effectiveness of absorption, and the reduced amount of plastic used in Grafysorber® booms and pillows. As a result of feedback from REDA Energy, Directa Plus has been able to further improve its oil spill response products, enhancing their ease of use and performance.

 

The first order from REDA for Grafysorber® products predates the Agreement and was delivered in June 2022 and comprised thousands of pillows and barriers. REDA will place a second similar order to build a minimum safety stock of products to cover northern Europe and will commence the distribution of Grafysorber® products to REDA customers.

 

Directa Plus's patented Grafysorber® technology is a graphene-based solution for treating water sludges and emulsions containing hydrocarbons and is at least five times more effective than current technologies - adsorbing more than 100 times its own weight of oil-based pollutants. In addition, Grafysorber® is sustainably produced, non-flammable and reusable, with the adsorbed hydrocarbons recoverable.

 

Commenting, Giulio Cesareo, Founder and CEO of Directa Plus, said: "Our environmental strategy is to offer our partners products designed to help their customers to achieve their sustainability targets more easily, more cheaply and faster. The Agreement with REDA represents an important milestone in the commercialisation of Grafysorber® products in international oil producing regions with the North Sea being the first. REDA brings added value capabilities to this key vertical for Directa Plus, accelerating the development and growth of our products and services."

 

For further information please visit http://www.directa-plus.com/ or contact:

 

Directa Plus plc

+39 02 36714458

Giulio Cesareo, CEO / Giorgio Bonfanti, CFO

Cenkos Securities plc (Nominated Adviser and Joint Broker)

+44 131 220 6939

Neil McDonald / Adam Rae

Singer Capital Markets (Joint Broker)

+44 20 7496 3069

Rick Thompson / Phil Davies

Tavistock (Financial PR and IR)

+44 20 7920 3150

Simon Hudson / Heather Armstrong

 

About Directa Plus

Directa Plus (www.directa-plus.com) is one of the largest producers and suppliers of graphene-based products for use in consumer and industrial markets. The Company's graphene manufacturing capability uses proprietary patented technology based on a plasma super expansion process. Starting from natural graphite, each step of Directa Plus' production process - expansion, exfoliation and drying - creates graphene-based materials and hybrid graphene materials ready for a variety of uses and available in various forms such as powder, liquid and paste.

 

This proprietary production process uses a physical process, rather than a chemical process, to process graphite into pristine graphene nanoplatelets, which enables Directa Plus to offer a sustainable, non-toxic product, without unwanted by-products. Directa Plus' products are made of hybrid graphene materials and graphene nano-platelets. The products (marketed as G+®) have multiple applications due to its properties. These G+® products can be categorised into various families, with different products being suitable for specific practical applications.

 

Directa Plus was established in 2005 and is based in Lomazzo (Como, Italy) and has been listed on the AIM market of the London Stock Exchange since May 2016. The Company holds the Green Economy Mark from London Stock Exchange which recognises companies that contribute to the global green economy.

 

About the REDA Group

The REDA group is a leading manufacturer and distributor providing industrial business-to-business solutions. Delivering a broad range of technology-based products and solutions in the fields of fire protection, safety and security, speciality chemicals, food ingredients, oilfield services, process and laboratory equipment.

 

With more than 2,600 employees worldwide, including 600 engineers and scientists, we have an unrelenting commitment to excellence in everything we do. The company operates an international network with more than 90 locations in 40 countries. The REDA group has evolved into a diversified enterprise with businesses across selected industrial sectors.

 

Contact

Gordon Moir (MD) +44 1224 937 888

 

-ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGREAKXPFAPAEFA
Date   Source Headline
15th Jan 20217:00 amRNSExercise of Options and Director / PDMR Dealing
11th Jan 20219:06 amRNSSecond Price Monitoring Extn
11th Jan 20219:00 amRNSPrice Monitoring Extension
11th Jan 20217:00 amRNSTrading Update
3rd Dec 20207:00 amRNSTrading Update
23rd Nov 20202:06 pmRNSSecond Price Monitoring Extn
23rd Nov 20202:01 pmRNSPrice Monitoring Extension
23rd Nov 202011:05 amRNSSecond Price Monitoring Extn
23rd Nov 202011:00 amRNSPrice Monitoring Extension
23rd Nov 20209:05 amRNSSecond Price Monitoring Extn
23rd Nov 20209:00 amRNSPrice Monitoring Extension
23rd Nov 20207:00 amRNSUpdate on Partner NexTech Batteries
17th Nov 20207:00 amRNSGrant of Options
26th Oct 20207:00 amRNSGraphene for Use in Lithium Sulphur Batteries
14th Oct 20207:00 amRNSSetcar Update
24th Sep 20207:00 amRNSHalf-year Report
9th Sep 20207:00 amRNSPublication of Scientific Paper
13th Aug 20207:00 amRNSCo-Mask Anti-Viral (COVID-19) Properties Confirmed
10th Aug 20207:00 amRNSAgreement with Poltrona Frau
4th Aug 20207:00 amRNSNew San Giorgio Bridge Opens with Gipave Asphalt
30th Jul 20207:00 amRNSItalian Patent Grant for Shoe Outsoles
29th Jul 20209:00 amRNSPrice Monitoring Extension
29th Jul 20207:00 amRNSAgreement with Italdesign
28th Jul 20207:00 amRNSAppointment of Nominated Adviser and Joint Broker
27th Jul 20204:46 pmRNSTotal Voting Rights
13th Jul 20207:00 amRNSAward of Waste Management Contract
1st Jul 202011:57 amRNSDirector/PDMR Shareholding
30th Jun 20207:00 amRNSDirector/PDMR Shareholding
26th Jun 202012:56 pmRNSResult of AGM
25th Jun 20207:00 amRNSGipave graphene asphalt trial in Kent
23rd Jun 202010:21 amRNSDirector/PDMR Shareholding
22nd Jun 20207:00 amRNSGrant of Chinese Patent
19th Jun 20207:00 amRNSLaunch of Co-Mask
1st Jun 20205:30 pmRNSPosting of Annual Report & Notice of AGM
26th May 20207:00 amRNSGrant of Key Textile Patent
21st May 20207:00 amRNSFinal Results
18th May 20207:00 amRNSTechnology Innovation Award from Frost & Sullivan
27th Apr 20207:00 amRNSEuropean Patent Grant
14th Apr 20202:06 pmRNSSecond Price Monitoring Extn
14th Apr 20202:01 pmRNSPrice Monitoring Extension
14th Apr 20207:00 amRNSAgreement with Iterchimica
30th Mar 20202:05 pmRNSSecond Price Monitoring Extn
30th Mar 20202:00 pmRNSPrice Monitoring Extension
23rd Mar 20207:00 amRNSCovid-19 Update
13th Mar 20207:00 amRNSTrading Update
12th Feb 20207:00 amRNSEco certification of graphene printing technology
3rd Feb 20207:00 amRNSAward of Environmental services contract
27th Jan 20207:00 amRNSEU Grant for Eco-friendly G+ Printing Technology
20th Jan 20207:00 amRNSR&D Agreement with Comerio Ercole
9th Dec 20197:00 amRNSAward of Environmental Services Contract

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.